564 related articles for article (PubMed ID: 15149786)
1. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.
Bumann D; Metzger WG; Mansouri E; Palme O; Wendland M; Hurwitz R; Haas G; Aebischer T; von Specht BU; Meyer TF
Vaccine; 2001 Dec; 20(5-6):845-52. PubMed ID: 11738748
[TBL] [Abstract][Full Text] [Related]
3. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.
Aebischer T; Bumann D; Epple HJ; Metzger W; Schneider T; Cherepnev G; Walduck AK; Kunkel D; Moos V; Loddenkemper C; Jiadze I; Panasyuk M; Stolte M; Graham DY; Zeitz M; Meyer TF
Gut; 2008 Aug; 57(8):1065-72. PubMed ID: 18417532
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers.
DiPetrillo MD; Tibbetts T; Kleanthous H; Killeen KP; Hohmann EL
Vaccine; 1999 Oct; 18(5-6):449-59. PubMed ID: 10519934
[TBL] [Abstract][Full Text] [Related]
5. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
Liu X; Hu J; Zhang X; Fan D
Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
[TBL] [Abstract][Full Text] [Related]
6. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli.
Hotz C; Fensterle J; Goebel W; Meyer SR; Kirchgraber G; Heisig M; Fürer A; Dietrich G; Rapp UR; Gentschev I
Int J Med Microbiol; 2009 Feb; 299(2):109-19. PubMed ID: 18706861
[TBL] [Abstract][Full Text] [Related]
8. Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.
Tacket CO; Galen J; Sztein MB; Losonsky G; Wyant TL; Nataro J; Wasserman SS; Edelman R; Chatfield S; Dougan G; Levine MM
Clin Immunol; 2000 Nov; 97(2):146-53. PubMed ID: 11027455
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM
Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
11. Human immune response towards recombinant Helicobacter pylori urease and cellular fractions.
Voland P; Zeitner M; Hafsi N; Prinz C
Vaccine; 2006 May; 24(18):3832-9. PubMed ID: 16122847
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system.
Kotton CN; Lankowski AJ; Scott N; Sisul D; Chen LM; Raschke K; Borders G; Boaz M; Spentzou A; Galán JE; Hohmann EL
Vaccine; 2006 Sep; 24(37-39):6216-24. PubMed ID: 16824652
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
Yang XL; Liu WC; Yang WW; Zhong D; Liu YH; Zhang JD; Jiang JH; Li SS
Biomed Environ Sci; 2005 Dec; 18(6):411-8. PubMed ID: 16544523
[TBL] [Abstract][Full Text] [Related]
14. Rational design of Salmonella recombinant vaccines.
Cheminay C; Hensel M
Int J Med Microbiol; 2008 Jan; 298(1-2):87-98. PubMed ID: 17888730
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.
Malfertheiner P; Schultze V; Rosenkranz B; Kaufmann SH; Ulrichs T; Novicki D; Norelli F; Contorni M; Peppoloni S; Berti D; Tornese D; Ganju J; Palla E; Rappuoli R; Scharschmidt BF; Del Giudice G
Gastroenterology; 2008 Sep; 135(3):787-95. PubMed ID: 18619971
[TBL] [Abstract][Full Text] [Related]
16. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
Corthésy B; Boris S; Isler P; Grangette C; Mercenier A
J Infect Dis; 2005 Oct; 192(8):1441-9. PubMed ID: 16170763
[TBL] [Abstract][Full Text] [Related]
17. Bacteremia associated with live attenuated chi8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers.
Frey SE; Bollen W; Sizemore D; Campbell M; Curtiss R
Clin Immunol; 2001 Oct; 101(1):32-7. PubMed ID: 11580224
[TBL] [Abstract][Full Text] [Related]
18. Recombinant antigen from Helicobacter pylori urease as vaccine against H. pylori-associated disease.
Fujii R; Morihara F; Fukushima K; Oku T; Hifumi E; Uda T
Biotechnol Bioeng; 2004 Jun; 86(7):737-46. PubMed ID: 15162449
[TBL] [Abstract][Full Text] [Related]
19. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.
Frey SE; Lottenbach KR; Hill H; Blevins TP; Yu Y; Zhang Y; Brenneman KE; Kelly-Aehle SM; McDonald C; Jansen A; Curtiss R
Vaccine; 2013 Oct; 31(42):4874-80. PubMed ID: 23916987
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
